Old Web
English
Sign In
Acemap
>
Paper
>
Survival benefit of cabazitaxel in castration-resistant prostate cancer patients predicted with poor prognosis
Survival benefit of cabazitaxel in castration-resistant prostate cancer patients predicted with poor prognosis
2018
Hashimoto Kohei
Tanaka Toshiaki
Tabata Hidetoshi
Takayanagi Akio
Shindo Tetsuya
Yamamoto Takanobu
Shibamori Kosuke
Kato Shuichi
Hashimoto Jiro
Inoue Ryuta
Muranaka Takashi
Takahashi Atsushi
Masumori Naoya
Keywords:
thesaurus
Cabazitaxel
Oncology
Internal medicine
survival benefit
Medicine
Prostate cancer
poor prognosis
castration resistant
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]